241 related articles for article (PubMed ID: 18473834)
1. Kinetoplast as a potential chemotherapeutic target of trypanosomatids.
Motta MC
Curr Pharm Des; 2008; 14(9):847-54. PubMed ID: 18473834
[TBL] [Abstract][Full Text] [Related]
2. Drug targets in kinetoplastid parasites. Preface.
Majumder HK
Adv Exp Med Biol; 2008; 625():vii-viii. PubMed ID: 18365653
[No Abstract] [Full Text] [Related]
3. Cellular trafficking in trypanosomatids: a new target for therapies?
Costa-Pinto D; Trindade LS; McMahon-Pratt D; Traub-Cseko YM
Int J Parasitol; 2001 May; 31(5-6):536-43. PubMed ID: 11334939
[TBL] [Abstract][Full Text] [Related]
4. The killing of African trypanosomes by ethidium bromide.
Roy Chowdhury A; Bakshi R; Wang J; Yildirir G; Liu B; Pappas-Brown V; Tolun G; Griffith JD; Shapiro TA; Jensen RE; Englund PT
PLoS Pathog; 2010 Dec; 6(12):e1001226. PubMed ID: 21187912
[TBL] [Abstract][Full Text] [Related]
5. Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi.
Zuma AA; Cavalcanti DP; Maia MC; de Souza W; Motta MC
Int J Antimicrob Agents; 2011 May; 37(5):449-56. PubMed ID: 21292448
[TBL] [Abstract][Full Text] [Related]
6. TbKAP6, a mitochondrial HMG box-containing protein in Trypanosoma brucei, is the first trypanosomatid kinetoplast-associated protein essential for kinetoplast DNA replication and maintenance.
Wang J; Pappas-Brown V; Englund PT; Jensen RE
Eukaryot Cell; 2014 Jul; 13(7):919-32. PubMed ID: 24879122
[TBL] [Abstract][Full Text] [Related]
7. Isobenzofuranone derivative JVPH3, an inhibitor of L. donovani topoisomerase II, disrupts mitochondrial architecture in trypanosomatid parasites.
Chowdhury SR; Godinho JLP; Vinayagam J; Zuma AA; Silva STM; Jaisankar P; Rodrigues JCF; De Souza W; Majumder HK
Sci Rep; 2018 Aug; 8(1):11940. PubMed ID: 30093616
[TBL] [Abstract][Full Text] [Related]
8. Kinetoplast DNA-binding protein profile in the epimastigote form of Trypanosoma cruzi.
Zavala-Castro JE; Acosta-Viana K; Baylon-Pacheco L; González-Robles A; Guzmán-Marín E; Rosales-Encina JL
Arch Med Res; 2002; 33(3):250-6. PubMed ID: 12031629
[TBL] [Abstract][Full Text] [Related]
9. Identification of new kinetoplast DNA replication proteins in trypanosomatids based on predicted S-phase expression and mitochondrial targeting.
Li Y; Sun Y; Hines JC; Ray DS
Eukaryot Cell; 2007 Dec; 6(12):2303-10. PubMed ID: 17965251
[TBL] [Abstract][Full Text] [Related]
10. Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases.
Battista T; Colotti G; Ilari A; Fiorillo A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326257
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and trypanosomatids: targets and drugs.
Fidalgo LM; Gille L
Pharm Res; 2011 Nov; 28(11):2758-70. PubMed ID: 21935742
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
Berg M; Van der Veken P; Goeminne A; Haemers A; Augustyns K
Curr Med Chem; 2010; 17(23):2456-81. PubMed ID: 20491648
[TBL] [Abstract][Full Text] [Related]
13. Acriflavine treatment promotes dyskinetoplasty in Trypanosoma cruzi as revealed by ultrastructural analysis.
Manchester T; Cavalcanti DP; Zogovich M; DE Souza W; Motta MC
Parasitology; 2013 Sep; 140(11):1422-31. PubMed ID: 23965822
[TBL] [Abstract][Full Text] [Related]
14. Knockout of the gene encoding the kinetoplast-associated protein 3 (KAP3) in Trypanosoma cruzi: effect on kinetoplast organization, cell proliferation and differentiation.
de Souza FS; Rampazzo Rde C; Manhaes L; Soares MJ; Cavalcanti DP; Krieger MA; Goldenberg S; Fragoso SP
Mol Biochem Parasitol; 2010 Aug; 172(2):90-8. PubMed ID: 20363262
[TBL] [Abstract][Full Text] [Related]
15. The rotational dynamics of kinetoplast DNA replication.
Liu Y; Englund PT
Mol Microbiol; 2007 May; 64(3):676-90. PubMed ID: 17462016
[TBL] [Abstract][Full Text] [Related]
16. Kinetoplast DNA minicircle binding proteins in a Leishmania Spp: interference of protein DNA interaction by berenil.
Singh R; Siddiqui KA; Valenzuela MS; Majumder HK
Indian J Biochem Biophys; 1995 Dec; 32(6):437-41. PubMed ID: 8714215
[TBL] [Abstract][Full Text] [Related]
17. Foreword. Trypanosomatid disease drug discovery and target identification.
N Setzer W
Future Med Chem; 2013 Oct; 5(15):1703-4. PubMed ID: 24144406
[No Abstract] [Full Text] [Related]
18. Fellowship of the rings: the replication of kinetoplast DNA.
Liu B; Liu Y; Motyka SA; Agbo EE; Englund PT
Trends Parasitol; 2005 Aug; 21(8):363-9. PubMed ID: 15967722
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
Das A; Dasgupta A; Sengupta T; Majumder HK
Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
[TBL] [Abstract][Full Text] [Related]
20. Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.
Cavalli A; Bolognesi ML
J Med Chem; 2009 Dec; 52(23):7339-59. PubMed ID: 19606868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
